Description
Active Ingredients:
Allo
Alopurinol
Every tablet contains 300 mg of ALLOPURINOL
Route of administration:
Oral
Presentation:
Box with 30 tablets
Sanitary Registration:
INVIMA 2011M-0012637
Therapeutical Indications:
Allopurinol is used to reduce the concentration of urate in body fluids and/or urine to prevent or eliminate the uric acid and urate deposits.
Counterindications
Hipersensitivity to the ingredient. Pregnancy. Breastfeeding. It must not be administered along with iron salts in renal or hepatic disfunction patients. It may strengthen the effect of coumarin blood-thinners.
Description
Isticol
Active Ingredients:
Every 100 ml of this product contain: Chlorpheniramine maleate 50 mg - Excipient, 100 mL.
Route of administration:
Oral
Presentation:
Jar x 120 mL
Sanitary Registration:
Invima 2010 M-000813-R3
Therapeutical Indications:
It is indicated for allergic affections, such as hay fever,
Está indicado en las afecciones alérgicas, como fiebre de heno, urticaria caused by medicines or by intolerance to certain foods, or by contact in allergic rinitis, vasomotor rinitis, insect stings, atopical dermatitis and allergic conjuntivitis.
Counterindications
It is counter indicated in patients that receive treatment with MAO inhibitors or in the 14 days after the suspension of such treatment. Monoamine oxidase (MAO) inhibitors lengthen and intensify the effects produced by anti histaminic, leading to risk of serious hipotension.
Description
Active Ingredients:
NEOFLUZ
Fluconazol
Every capsule contains Flucconazole 200 mg
Route of administration:
Oral
Presentation:
Box x 4 capsules
Sanitary Registration
INVIMA 2014M-0015030
Therapeutical Indications:
Indicated in the treatment of oropharyngeal, esophageal and vaginal candidiasis. Cryptococcosis, including meningitis and other infections (pulmonar, etc.), candidaemia, systemic candidiasis infections and other invasive forms of infection. In general, any localized or systemic mycosis that is sensitive to the substance. Prevention of fungal diseases in cancer patients or people who are receiving chemotherapy or radiotherapy.
Counterindications
Hypersensitivity to Flucconazole or triazolic derivates. Dual administration of Terfenadine is counter indicated in patients who are taking Flucconazole. Dual administration of Flucconazole and drugs known to increase the QT interval and that are metabolized through the CYP3A4 enzyme, such as Cisaprida, astemizole, erytromycin, pimozide and quinidine, is counter indicated. Pregnancy (C/D category).
Description
Colirio
AZUL
Active Ingredients:
Every 100 ml of product contain XILOMETAZOLINE HYDROCLORIDE 0,50 mg
Excipient, c.s.p 100 mL
Route of administration:
Conjunctival
Presentation:
Plástico dropper bottle x 10 mL.
Sanitary Registration:
INVIMA 2012M-002120-R2
Therapeutical Indications:
For the control of conjunctival hyperemia of any type or a condition characterized by vascularization of the corneal surface. When an intense vasoconstrictor action of 6 to 8 hours is required. Conjunctival decongestant.
Counterindications
Hypertension, hyperthyroidism, hipersensitivity to the substance, narrow-angle glaucoma. Use with caution in patients with cardiac disorders.
This is a medicine, do not exceed the indicated dose, read the indications and counterindications. If the symptoms persist, consult a doctor.
ALLO ALOPURINOL Sanitary registration INVIMA 2011M-0012637- ISTICOL Sanitary registration INVIMA 2010 M-000813-R3 - NEOFLUZ Sanitary registration INVIMA 2014M-0015030 - COLIRIO AZUL Sanitary registration INVIMA 2012M-002120-R2